BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10332431)

  • 1. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urolithiasis associated with protease inhibitors.
    Sundaram CP; Saltzman B
    J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].
    Kalaitzis C; Touloupidis S; Patris E; Lehrich K; Kuntz RM
    Urologe A; 2004 Feb; 43(2):168-71. PubMed ID: 14991118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
    Reiter WJ; Schön-Pernerstorfer H; Dorfinger K; Hofbauer J; Marberger M
    J Urol; 1999 Apr; 161(4):1082-4. PubMed ID: 10081842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors and urolithiasis.
    Sutherland SE; Reigle MD; Seftel AD; Resnick MI
    J Urol; 1997 Jul; 158(1):31-3. PubMed ID: 9186316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal lithiasis due to indinavir].
    Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.
    Kalaitzis C; Dimitriadis G; Tsatidis T; Kuntz R; Touloupidis S; Kelidis G
    Int Urol Nephrol; 2002; 34(1):13-5. PubMed ID: 12549631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary lithiasis secondary to medication in HIV+ patients receiving Indinavir].
    Juan Escudero JU; López Alcina E; Ordoño Domínguez F; Fabuel Deltoro M; Serrano de la Cruz Torrijos F; Montoliu García A; Ramada Benlloch F; Marqués Vidal E
    Arch Esp Urol; 2008; 61(1):35-40. PubMed ID: 18405026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urolithiasis and the protease inhibitor indinavir.
    Hermieu J; Prévot M; Ravery V; Sauty L; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Eur Urol; 1999; 35(3):239-41. PubMed ID: 10072627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index.
    Meraviglia P; Angeli E; Del Sorbo F; Rombolà G; Viganò P; Orlando G; Cordier L; Faggion I; Cargnel A
    AIDS; 2002 Oct; 16(15):2089-93. PubMed ID: 12370513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyuria in patients treated with indinavir is associated with renal dysfunction.
    Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
    Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indinavir urolithiasis.
    Wu DS; Stoller ML
    Curr Opin Urol; 2000 Nov; 10(6):557-61. PubMed ID: 11148725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydration.
    Hug B; Naef M; Bucher HC; Sponagel L; Lehmann K; Battegay M
    BJU Int; 1999 Oct; 84(6):610-4. PubMed ID: 10510102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging characteristics of indinavir calculi.
    Schwartz BF; Schenkman N; Armenakas NA; Stoller ML
    J Urol; 1999 Apr; 161(4):1085-7. PubMed ID: 10081843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.